=Ab s t r a c t = P u r p o s e: To investigate the effects of angiotensin II inhibition on the epithelial to mesenchymal transition (EMT) in the developing kidney, we tested the expression of EMT markers and nestin in angiotensin converting enzyme (ACE) inhibitor-treated kidneys. Me t h o d s: Newborn rat pups were treated with enalapril (30 mg/kg/d) or a vehicle for 7 days. Immunohistochemistry for the expression of α-smooth muscle actin (SMA), E-cadherin, vimentin, and nestin were performed. The number of positively-stained cells was determined under 100 magnification in 10 random fields. Re s u l t s: In the enalapril-treated group, αSMA-positive cells were strongly expressed in the dilated tubular epithelial cells.
I n t r o d u c t i o n
Dynamic cellular transitions, switching between the epithelial and mesenchymal states, are pivotal events during embryogenesis and organogenesis 1) . The epithelial to mesenchymal transition (EMT) and the mesenchymal to epithelial transition (MET) occur at multiple occasions during development, tumor progression and organ fibrosis 2, 3) . Over the past several years, there has been substantial progress in demonstrating the significance of the EMT in chronic kidney disease 4) . The enhanced conversion of the renal tubular epithelial cells to myofibroblasts/fibroblasts via the EMT leads to the disruption of polarized renal tubular epithelial layers and an increase in fibrotic scar formation 5) .
Of note, is that the conversion of the metanephric mesenchyme into epithelium via the MET is a fundamental process during kidney development. Reciprocal inductive interactions between the metanephric mesenchyme and ureteric bud transform the ureteric bud into the renal collecting system; this occurs while the metanephric mesenchyme condenses and subsequently undergoes MET to give rise to nephrons 1) . In this context, the renal EMT may be characterized as a process of reverse embryogenesis. There is a great deal of experimental data on the modulation of the EMT, as a novel therapeutic target, in the setting of chronic renal fibrosis 6, 7) . A substantial number of EMT inducers and mediators have been studied and among them, αSMA, E-cadherin and vimentin have been identified as markers of both the EMT and the MET.
During the EMT associated with renal fibrosis, tubular epithelial cells lose the epithelial cell marker E-cadherin and acquire mesenchymal features, characterized by αSMA and vimentin markers 8, 9) . Cadherin-mediated adhesion is a vital component for determining and maintaining the epithelial phenotype; the role that E-cadherin plays in modulating the epithelial phenotype and expression patterns during kidney MET is of great interest 1) .
Nestin is considered a marker of neurogenic and myogenic precursor cells; however, relatively little is known about its role in the kidney. In the developing kidney, nestin has been detected in immature glomerular podocytes and proximal tubular epithelial cells 10, 11) . Nestin has been shown to be associated with vimentin in, in vivo and in vitro studies, suggesting the possibility of nestin expression in vimentin-positive cells of injured kidneys 12) . In the antiThy1 nephritis experimental model, most mesangial cells have been shown to express nestin associated with the activation marker αSMA and the proliferation marker 13) .
The renin-angiotensin system (RAS) has been implicated as a potent mitogen for the regulation of genes involved in cell proliferation and growth of the developing kidney; in addition, it is a major factor involved in the development of renal disease 14) . We and others have demonstrated that the neonatal interruption of angiotensin II induces renal growth impairment that is linked to renal papillary atrophy and tubulointerstitial damage; these abnormalities are characterized by tubular dilatation/atrophy and interstitial inflammation/fibrosis 15, 16) . Given the fact that abnormal renal development is linked to subsequent susceptibility to cardiovascular disease in adulthood, and RAS is a candidate for perinatal programming, the RAS-mediation of renal development is an important focus of study 17) .
The neonatal rat is a useful model for kidney developmental studies. Rats are born with immature kidneys and they undergo considerable postnatal renal development. The developing rat kidney is dependent on an intact RAS from gestational day 15 to postnatal day 13. All components of the RAS are crucially expressed in the developing kidney in a spatial and temporal pattern 18) . In the present study, we investigated the effects of angiotensin (Ang) II inhibition on the EMT in the developing rat kidney. We examined the expression of EMT markers and nestin in angiotensin converting enzyme (ACE) inhibitor-treated rat kidneys.
Ma t e r i a l sa n dMe t h o d s
Neonatal rat pups from pregnant Sprague Dawley rats were breastfed by their mothers throughout the study. They were treated with 30 mg/kg of enalapril (the enalapriltreated group, n=22) or vehicle (the control group, n=16) via an orogastric tube daily from birth. This dose of enalapril is known to block the effects of Ang II 19) . The rats were sacrificed at eight days of age (N8), and their kidneys were processed for the study. All rats were used in accordance with Low magnification of the kidney shows that αSMA is more intensely detected in the medullary and cortical cells in the enalapril-treated group, compared to the controls (A, B). αSMA is faintly observed only in the vascular smooth muscle cells and some interstitial cells in the control kidneys (C, E) (arrows); however, αSMA was more strongly stained in the renal cortex and medulla, especially in the dilated tubular epithelial cells in the enalapril-treated group (D, F) (arrows). The number of αSMA-positive cells was increased in both the renal cortex and medulla of the enalapril-treated group (G, H) ( * P<0.05) (black bar: control, white bar: enalapril-treated group) (A, B original magnification ×40; C, D ×200; E, F ×400). reaction products were developed using 3, 3-diaminobenzidine as the chromogen, at the standard development times. The sections were counterstained in 0.5% methyl green solution (Trevigen, Gaitisburg, MD, USA) for 5 min, dehydrated, and evaluated using light microscopy (×400). The number of positively-stained cells was determined under 100 magnification in 10 random fields.
.St a t i s t i c a la n a l y s i s
Data are presented as the mean±SEM. Differences between the groups were analyzed by the Student s t-test.
Statistical significance was defined as a P<0.05. The SigmaStat version 2.0 for Windows was used for the analysis.
Re s u l t s
.Ex p r e s s i o no fαSMA
For the immunochemical staining, αSMA was more intensely expressed in the medullary and cortical dilated tubular cells in the enalapril-treated group, compared to the controls (Fig. 1A-F) . In the control group, αSMA was weakly detected only in the vascular smooth muscle cells and in some interstitial cells; there was scant expression of αSMA in the tubular epithelial cells and glomeruli (Fig.   1A, C and E) . In the enalapril-treated group, αSMA was observed to be highly expressed in the dilated tubular epithelial cells (Fig. 1B, D and F) . The number of α SMA-positive cells significantly increased in both the renal cortex and medulla in the enalapril-treated group (P<0.05) ( Fig. 1G and H) .
.Ex p r e s s i o no fE-c a d h e r i n
In the control group, E-cadherin was intensely expressed in the developing medullary and cortical regions and in the maturing tubular epithelial cells, compared to the enalapriltreated group ( Fig. 2A-F) . The immunohistochemical staining showed that E-cadherin expression was easily . Low magnification of kidney shows E-cadherin staining in the control group was highly expressed in the renal cortex and medulla, compared to the enalapril-treated group (A, B). E-cadherin was clearly detectable within the glomeruli and the developing and maturing tubules in the cortex and medulla of the control kidneys (C) (E) (arrows). In the enalapril-treated kidneys, E-cadherin expression was faintly observed at some dilated cortical and medullary tubular epithelial cells (D, F) (arrows). E-cadherin-positive cells were considerably reduced in the cortex and medulla of the enalapril-treated group (G, H) ( * P<0.05) (black bar: control, white bar: enalapril-treated group) (A, B original magnification ×40; C, D, E, F ×400).
detected within glomeruli and tubular epithelial cells throughout the cortex and medulla in the control N8 kidneys (Fig. 2A, C and E) . In the enalapril-treated group, E-cadherin was weakly observed in some dilated tubular epithelial cells (Fig. 2B, D and F) . The expression of E-cadherin-positive cells was dramatically reduced in the cortex and medulla in the enalapril-treated group (P<0.05) (Fig. 2G and H) .
.Ex p r e s s i o no fv i me n t i n
In the enalapril-treated group, vimentin expression in the renal medulla was more prominent than in the control group, and almost all medullary interstitial cells showed strong positive vimentin staining (Fig. 3A-F) . In the control group, vimentin was detected in the vascular endothelial cells, glomeruli and medullary interstitial cells (Fig. 3A, C and E) .
The expression of vimentin was stronger in almost all of the medullary interstitial cells in the enalapril-treated group, compared to the controls (Fig. 3B, D and F) . The number of vimentin-positive cells was not different in the renal cortex between the two groups; however, the expression increased in the medullary tubulointerstitail cells in the enalapril-treated group (P<0.05) (Fig. 3G and H) .
.Ex p r e s s i o no fn e s t i n
Nestin-positive cells were more strongly expressed in the medullary tubulointerstitial cells in the enalapril-treated group, compared to the controls (Fig. 4A-F) . The expression of the nestin-positive cells in the renal cortex was observed in the glomeruli, endothelial cells of arterioles, and a few tubular cells; it was not much different from that of the control group (Fig.4C and D) . Nestin was more abundantly detected in the dilated medullary tubular epithelial cells in the enalapril-treated group (Fig.4E and F) . The number of nestin-positive cells was not different in the renal cortex of the two groups; however, the expression of nestin increased in medullary tubulointerstitial cells of the enalapril-treated group (P<0.05) (Fig. 4G and H) . 
Di s c u s s i o n
The main finding of the present study was that ACE inhibition, in the developing rat kidney, increased the renal EMT.
We demonstrated that ACE blockade, in the newborn rat kidney, up-regulated the dilated tubular expression of αSMA, a representative mesenchymal marker, and down-regulated the expression of the most common epithelial cell marker, E-cadherin. Enalapril treatment was associated with increased expression of vimentin and nestin in the renal medulla; however, there were no significant changes noted in the renal cortex. These results suggest that the RAS is important for modulating the renal EMT of the developing kidney, and that medullary tubulogenesis via renal MET or . Accumulating evidence suggests that Ang II is the key modulator of renal fibrosis and EMT. In cultured tubuloepithelial cells, Ang II induces αSMA expression and mesenchymal features 21) . Infusion of Ang II into rats causes tubular injury associated with the neoexpression of αSMA and vimentin in the renal interstitial cells 22, 23) ; therefore, it is reasonable to speculate that Ang II might be involved in the EMT of the kidney.
The results of the present study indicated, for the first time, that enalapril treatment promotes renal EMT and hinders renal MET in the developing rat kidney. In accordance with tubular dilatation and interstitial damage caused by ACE inhibition, the expression of mesenchymal markers (αSMA and vimentin) Fig. 4 . Immunohistological examination of nestin in the rat newborn control kidneys (A, C, E) and in the enalapril-treated kidneys (B, D, F). Low magnification of the kidney shows nestin expression in the renal medulla was more strongly stained in the enalapril-treated group, compared to the controls (A, B). In the cortex of both groups, nestin was detectable within the glomeruli, vascular endothelial cells and a few tubular cells; the immunoactivities did not differ between the two groups (C, D) (arrows). In the renal medulla of the enalapril-treated kidneys, nestin was more highly detected at the dilated tubular epithelial cells, compared to the controls (E, F) (arrows). The number of nestin-positive cells in the renal cortex was not different between the two groups; however, their expression in the medulla was increased in the enalapril-treated group (G, H) ( * P< 0.05) (black bar: control, white bar: enalapril-treated group) (A, B original magnification ×100; C, D, E, F ×400).
and nestin increased, and the expression of the epithelial marker (E-cadherin) decreased. These changes were more evident in the renal medulla than in the cortex of the enalapril-treated rats. Consistent with our findings, prior reports have indicated that the interruption of Ang II signaling during nephrogenesis in neonatal rats perturbs renal tubular development. Lasaitiene et al 24) showed that neonatal losartan treatment caused significant changes in the phenotype of the developing medullary and cortical regions as well as a thick ascending limb of Henle. ACE inhibition in the neonatal rat has a detrimental effect on the tubular mitochondrial structure and function during renal morphogenesis 25) . Enalapril treatment also caused a reduced expression of E-cadherin in dilated medullary collecting tubules, suggesting that suppressed E-cadherin levels could be involved in the development of tubular dilatation and that RAS is important in mediating normal medullary tubulogenesis 26) .
The expression of αSMA has been used as a marker for myofibroblasts, a subset of fibroblasts that are a major source of collagen synthesis 27) . Indeed, increasing numbers of αSMA-positive myofibroblasts has been associated with progressive renal dysfunction in many experimental studies 28) . α SMA may provide a structural foundation not only for defining the morphology of transformed cells, but also for their migration, invasion, and their capacity for contractility. αSMA-positive tubular epithelial cells are a stable, terminallydifferentiated, irreversible, transformed cell type 29) . In the . The suppression of E-cadherin expression is regarded as a key step that precedes other major events during renal EMT. The importance of E-cadherin in the development of normal epithelium has been established in gene knockout mice 31) . We found that the expression of E-cadherin was significantly decreased in the cortical and medullary dilated tubules of the enalapril-treated group.
Under normal conditions, E-cadherin expression was easily . Sakairi et al 37) showed that the degree of nestin expression was correlated with the degree of tubulointerstitial fibrosis in the adult rat kidney following unilateral ureteral obstruction. The nestin-positive tubular cells expressed vimentin,
indicating that these cells reverted to a mesenchymal phenotype. After experimental mesangial cell injury in vivo, glomerular nestin was also transiently increased during the repopulation phase. Nestin promoted mesangial cell proliferation in vitro, supporting a role for nestin during repair reactions 13) . In this study, we found that nestin was expressed in glomeruli, endothelial cells of arterioles, and a few tubular cells involved in the control of the developing kidneys, consistent with the findings of others 10, 11) . In ACE 
